Pharma News Briefs

  • The Wall St. Journal Health Blog had an interesting post Thursday on how Genzyme's struggle to produce enough Myozyme heightens worries about generic biotech drugs.
  • The New York Times published an interesting article Wednesday on the recent "tidal wave" and the coming "golden era" of generic drugs.
  • Novartis lost its challenge to India's drug patent law on Monday (see New York Times; Business Week; WSJ Health Blog). PhRMA reacted in this press release.
  • The Spicy IP blog has been providing a thoughtful, in-depth perspective on the Novartis India case.
  • FDA Law Blog reported Monday that the House passed an FDA appropriations bill with a provision allowing for reimportation of prescription drugs.
  • MarketWatch.com had this interesting article Monday on recent growth in pharmaceutical R&D in China and India.